Related Experiment Videos

Reduced secretion of IL-1 beta by peritoneal cells from patients on continuous ambulatory peritoneal dialysis

P H Hart1, C A Jones, K L Jones

  • 1Department of Microbiology & Infectious Diseases, School of Medicine, Flinders University of South Australia, Adelaide.

Insights

Peritoneal monocytes/macrophages from continuous ambulatory peritoneal dialysis (CAPD) patients produce less interleukin (IL)-1 beta during infection. These cells rapidly lose their ability to secrete IL-1 beta, suggesting intracellular utilization in vivo.

Area of Science:

  • Immunology
  • Nephrology
  • Cell Biology

Background:

  • Continuous ambulatory peritoneal dialysis (CAPD) patients are susceptible to peritonitis.
  • Interleukin (IL)-1 beta is a key pro-inflammatory cytokine involved in immune responses.

Purpose of the Study:

  • To investigate the production and secretion of IL-1 beta by peritoneal monocytes/macrophages in CAPD patients, particularly during infection and inflammation.

Main Methods:

  • In vitro culture of peritoneal monocytes/macrophages from CAPD patients.
  • Measurement of immunoreactive and bioactive IL-1 beta in cell supernatants and lysates.
  • Comparison with blood monocytes and pulmonary alveolar macrophages.

Main Results:

  • Peritoneal cells from CAPD patients secreted a significantly lower proportion of total IL-1 beta compared to blood monocytes.
  • Inflammatory peritoneal cells showed a higher proportion of cell-associated IL-1 beta, similar to differentiated macrophages.
  • Reduced IL-1 beta secretion was observed even in CAPD patients without peritonitis.

Conclusions:

  • Extravasated monocytes/macrophages in CAPD patients rapidly lose their capacity to secrete IL-1 beta.
  • A significant portion of IL-1 beta may be intracellularly located and utilized in vivo during peritonitis.

Related Concept Videos